Dear John McCafferty CEO and founder of IONTAS will be presenting on "The potential of recombinant antibody technology in venom therapeutics" as a Plenary Speaker at the 19th European Congress of the International Society on Toxinology.
Dear John McCafferty CEO and founder of IONTAS will be presenting on "The potential of recombinant antibody technology in venom therapeutics" as a Plenary Speaker at the 19th European Congress of the International Society on Toxinology.
